BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
MELVILLE, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (тАЬBioRestorativeтАЭ,…
Medkart Launches India's First Tool to Find Substitute Medicine and Compare Prices, Transforming Access to Affordable Healthcare
In a significant stride towards affordable healthcare, Medkart Pharmacy has unveiled India's…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Medkart Introduces India's First Room-Temperature Stable Nicorandil Tablets, Enhancing Accessibility to Cardiac Care
In a country where cardiac care costs continue to burden millions, Medkart…
Medkart Launches Women-First Franchise Drive to Empower Local Health Leaders
Across India, women have long been the backbone of community health тАФ…
Not Just Pharmacy: How Medkart is Building India's Smartest Generic Medicine App
IndiaтАЩs pharmaceutical landscape is undergoing a vital transformation. Despite being home to…
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
At ASHG, an early access customer from the London Health Sciences Center…
Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology
The Nobel Prize 2025has been awarded to Mary E. Brunkow, Fred Ramsdell,…
рдиреЛрдмреЗрд▓ рдкреБрд░рд╕реНрдХрд╛рд░ 2025 тАУ рдореЗрдбрд┐рд╕рд┐рди рдХреИрдЯреЗрдЧрд░реА рдореЗрдВ рддреАрди рд╡реИрдЬреНрдЮрд╛рдирд┐рдХреЛрдВ рдХреА рд╢рд╛рдирджрд╛рд░ рдЬреАрдд!
рд╣рд░ рд╕рд╛рд▓ рдХреА рддрд░рд╣ рдЗрд╕ рд╕рд╛рд▓ рднреА рдЕрдХреНрдЯреВрдмрд░ рдХреА рд╢реБрд░реБрдЖрдд рдореЗрдВ рдШреЛрд╖рд┐рдд…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…